A vaccine candidate, referred to as “future-proof,” is being touted as a potential “cure-all” against all forthcoming versions of SARS-CoV-2, the causative agent of COVID-19. A group of researchers from the University of Cambridge, England, in collaboration with DIOSynVax, a spin-off company, are harnessing innovative new technology to develop the vaccine. Research conducted on guinea… Read More »Cambridge Researchers Close to ‘Breakthrough’ Vaccine to Protect Against ALL Coronaviruses
The post Cambridge Researchers Close to ‘Breakthrough’ Vaccine to Protect Against ALL Coronaviruses appeared first on Becker News.
Source: Becker News – Read More